Medicare Enrolled

Dr. James Martin, MD

Neurology · Tallahassee, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1401 CENTERVILLE RD STE 600, Tallahassee, FL 32308
8508788121
In practice since 2006 (20 years)
NPI: 1982671053 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Martin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Martin

Dr. James Martin is a neurology in Tallahassee, FL, with 20 years in practice. Based on federal Medicare data, Dr. Martin performed 641 Medicare services across 439 unique beneficiaries.

Between the years covered by Open Payments, Dr. Martin received a total of $11,329 from 79 pharmaceutical and/or device companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Martin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 43% volume in FL$ $11,329 industry payments

Medicare Practice Summary

Medicare Utilization ↗
641
Medicare services
Top 43% in FL for neurology
439
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Needle measurement of electrical activity in arm or leg muscles, complete study389$74$311
Nerve conduction, 11-12 studies134$187$2,200
Nerve conduction, 7-8 studies64$131$1,700
Nerve conduction, 9-10 studies16$159$2,000
Office visit, established patient (20-29 min)16$72$378
Nerve conduction, 13 or more studies11$205$2,500
New patient office visit (30-44 min)11$86$378
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,329
Total received (2018-2024)
Avg $1,618/year across 7 years
Top 25% in FL for neurology
79
Companies
777
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,269 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,504
2023
$1,731
2022
$1,516
2021
$808
2020
$846
2019
$2,037
2018
$1,887

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$932
Supernus Pharmaceuticals, Inc.
$705
ABBVIE INC.
$623
Amgen Inc.
$572
SK Life Science, Inc.
$551
Lilly USA, LLC
$528
Greenwich Biosciences, Inc.
$481
Lundbeck LLC
$433
UCB, Inc.
$386
Eisai Inc.
$341
EISAI INC.
$331
Alexion Pharmaceuticals, Inc.
$330
Sunovion Pharmaceuticals Inc.
$288
Neurelis, Inc.
$283
GENZYME CORPORATION
$257
JAZZ PHARMACEUTICALS INC.
$253
Horizon Therapeutics plc
$250
Biogen, Inc.
$212
Teva Pharmaceuticals USA, Inc.
$203
CATALYST PHARMACEUTICALS, INC.
$197
US WorldMeds, LLC
$173
CSL Behring
$172
Kyowa Kirin, Inc.
$150
ARGENX US, INC.
$142
Jazz Pharmaceuticals Inc.
$139
Mitsubishi Tanabe Pharma America, Inc.
$129
Adamas Pharmaceuticals, Inc.
$118
Mallinckrodt LLC
$110
ACADIA Pharmaceuticals Inc
$106
Biohaven Pharmaceutical Holding Company Ltd.
$95
Avanir Pharmaceuticals, Inc.
$89
Genentech USA, Inc.
$89
AstraZeneca Pharmaceuticals LP
$86
Grifols USA, LLC
$86
Otsuka America Pharmaceutical, Inc.
$79
MITSUBISHI TANABE PHARMA AMERICA, INC.
$78
Neurocrine Biosciences, Inc.
$76
Acorda Therapeutics, Inc
$60
E.R. Squibb & Sons, L.L.C.
$59
Shire North American Group Inc
$56
Catalyst Pharmaceuticals, Inc.
$49
Nevro Corp.
$47
Ironshore Pharmaceuticals Inc.
$45
AbbVie, Inc.
$44
Banner Life Sciences, LLC
$42
Biohaven Pharmaceuticals, Inc.
$42
Avion Pharmaceuticals
$40
Bayer HealthCare Pharmaceuticals Inc.
$40
Mallinckrodt Hospital Products Inc.
$40
BANNER LIFE SCIENCES, LLC
$39
Celgene Corporation
$38
Axsome Therapeutics, Inc.
$38
Allergan Inc.
$37
PFIZER INC.
$36
Mallinckrodt Enterprises LLC
$33
Merz North America, Inc.
$32
DePuy Synthes Sales Inc.
$31
Alnylam Pharmaceuticals Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Janssen Pharmaceuticals, Inc
$29
Almatica Pharma LLC
$26
AbbVie Inc.
$25
Impax Laboratories, Inc.
$22
Medtronic, Inc.
$21
EMD Serono, Inc.
$21
Merz Pharmaceuticals, LLC
$19
Strongbridge US INC.
$18
Akcea Therapeutics, Inc.
$18
Electromed, Inc.
$18
Daiichi Sankyo Inc.
$16
Merck Sharp & Dohme LLC
$14
SCILEX PHARMACEUTICALS INC.
$14
Boston Scientific Corporation
$13
Neos Therapeutics, LP
$13
PORTOLA PHARMACEUTICALS, INC.
$13
Upsher-Smith Laboratories LLC
$13
ARBOR PHARMACEUTICALS, INC.
$12
Promius Pharma LLC
$12
Abbott Laboratories
$12
Top 3 companies account for 20.0% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · Cotempla XR-ODT · DUOPA · Dhivy · Duopa · EMGALITY · EPIDIOLEX · EXPAREL · Epidiolex · Evrysdi · FARXIGA · FIRDAPSE · FLUMIST QUADRIVALENT · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · JORNAY PM · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAYZENT · MYOBLOC · Morphabond ER · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · ONPATTRO · OXTELLAR XR · Ocrevus · Omnia · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rystiggo · SKYCLARYS · SMARTVEST · SOLIRIS · SUNOSI · Senza · Skyclarys · Soliris · Sunosi · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · XEOMIN · XYREM · Xadago · Xeomin · ZEPOSIA · ZTLido · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,767 per 100 Medicare services performed
Looking for a neurology in Tallahassee?
Compare neurologys in the Tallahassee area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
20
Per 100K population
6.8
County median income
$65,074
Nearest hospital
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Martin is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Martin experienced with needle measurement of electrical activity in arm or leg muscles, complete study?
Based on Medicare claims data, Dr. Martin performed 389 needle measurement of electrical activity in arm or leg muscles, complete study services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martin receive payments from pharmaceutical companies?
Yes. Dr. Martin received a total of $11,329 from 79 companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martin's costs compare to other neurologys in Tallahassee?
Dr. Martin's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →